CytoSorbents Corporation (CTSO)

[techxen]

From what I remember from the conference call last week with the KOL's on the removal of ticagrelor, they are basing the pricing on what the cost savings were from the UK study on cost-effectiveness last year, that demonstrated a savings of approximately $5,000 per case due to the clinical benefits. If the recording is still available, Dr. Chan does address the $5,000 pricing briefly.

I admit I am also a bit confused because Dr. Schmoeckel was asked during that call how many cartridges are used typically and he said only one.

They must feel that they have the basis for this pricing as it has been mentioned on multiple conference calls and appears in several presentations.